Panbela Therapeutics, Inc. Proceeds from Notes Payable
Panbela Therapeutics, Inc. reported Proceeds from Notes Payable of $2.20 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2024-11-14
- 2024-09-30: Proceeds from Notes Payable 9 month $2.20M.
- 2023-09-30: Proceeds from Notes Payable 9 month $0.00.
| Period end | Proceeds from Notes Payable 9 month |
|---|---|
| 2024-09-30 | $2.20M 10-Q · filed 2024-11-14 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 |